Myofascial Trigger Points of the Levator Scapulae Muscle

May 3, 2023 updated by: JORGE VELAZQUEZ SAORNIL, Universidad Católica de Ávila

Sonoelastography, Tensiomyography and Mechanosensitivity Between Latent, Active and Control Trigger Points in Myofascial Trigger Points of the Levator Scapulae Muscle.

Chronic neck pain (CNP) is considered one of the most common musculoskeletal disorders worldwide and myofascial pain syndrome (MPS) is the most prevalent musculoskeletal disorder in the majority of the population. However, normal tissue contractility changes and the different types of myofascial trigger points (MTrPs) measured by tensiomography have not yet been studied. For this reason, the aim of our study is to determine the differences in pressure pain threshold (PPT), tensiomyography and sonoelastography between the palpation zone of control points with respect to active and latent MTrPs in the levator scapulae muscles of subjects with CNP. A single-blind descriptive cross-sectional study is conducted with a convenience sample of 60 points (20 active, 20 latent and 20 control points) on both sides of the subject in the levator scapulae muscles of individuals diagnosed with CNP.

The order of outcome measurements for each point was PPT, manual tension index sonoelastography and tensiomyography separated by 15 minutes. Objective contractile parameters were: contraction time (Tc), mean relaxation time (Tr), maximum radial displacement (Dm), holding time (Ts) and delay time (Td).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Ávila, Spain, 05005
        • Universidad Católica de Ávila

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Bilateral presence of at least one active trigger point.
  • One control point and one latent trigger point in the levator scapulae muscles.
  • Subjects aged between 18 and 65 years.
  • Subjects diagnosed with chronic neck pain for more than 6 weeks.
  • Signed informed consent to be able to participate in the study.

Exclusion Criteria:

  • Previous treatment for chronic neck pain (within one year) or medical history with a diagnosis of neuropathy.
  • Rheumatoid arthritis.
  • Myopathy.
  • Cognitive impairment or mental disability.
  • Skin disorders.
  • Pregnancy.
  • Activity level of a high-level athlete.
  • Medical conditions (fractures, structural deformities and neoplasms).
  • Surgical interventions in the cervical-dorsal region or upper extremities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ischemic Compression group
IC group with conservative technique in trigger points in levator scapulae muscle
Diagnostic test: Sonoelastography, tensiomyography and mechanosensitivity
To observe the differences between the different trigger points of the levator scapulae muscle by means of different diagnostic options.
Active Comparator: Dry needling group
Dry needling group with invasive technique in trigger points in levator scapulae muscle
Diagnostic test: Sonoelastography, tensiomyography and mechanosensitivity
To observe the differences between the different trigger points of the levator scapulae muscle by means of different diagnostic options.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
manual tension index sonoelastography
Time Frame: 1 week
Measurement of manual ultrasound transducer tension on the trigger point of the levator scapulae
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
tensiomyography
Time Frame: 1 week
Ultrasound transducer tensiomyography measurement of the levator scapulae trigger point
1 week
minimum intensity of a stimulus that elicits the sensation of pain (pressure pain threshold).
Time Frame: 1 week
patient-tolerable pain at the trigger point of the levator scapulae muscle measured by algometer.
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Católica de Ávila

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2022

Primary Completion (Actual)

September 21, 2022

Study Completion (Actual)

December 28, 2022

Study Registration Dates

First Submitted

March 6, 2023

First Submitted That Met QC Criteria

March 16, 2023

First Posted (Actual)

March 20, 2023

Study Record Updates

Last Update Posted (Estimate)

May 5, 2023

Last Update Submitted That Met QC Criteria

May 3, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 03/23

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myofascial Pain Syndrome

Clinical Trials on Sonoelastography, tensiomyography and mechanosensitivity

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe